home / stock / celuw / celuw quote
Last: | $0.02 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0153 |
Close: | $0.02 |
High: | $0.02 |
Low: | $0.0153 |
Volume: | 1,617 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.02 | $0.0153 | $0.02 | $0.02 | $0.0153 | 1,617 | 07-04-2024 |
$0.02 | $0.0153 | $0.02 | $0.02 | $0.0153 | 1,617 | 07-03-2024 |
$0.0153 | $0.0153 | $0.0153 | $0.0153 | $0.0153 | 400 | 07-02-2024 |
$0.0154 | $0.0198 | $0.0154 | $0.0198 | $0.0154 | 400 | 07-01-2024 |
$0.0152 | $0.0155 | $0.0152 | $0.01755 | $0.0151 | 5,600 | 06-27-2024 |
$0.0152 | $0.0153 | $0.0152 | $0.0153 | $0.0152 | 3,916 | 06-26-2024 |
$0.018 | $0.016 | $0.018 | $0.018999 | $0.0152 | 29,167 | 06-25-2024 |
$0.0179 | $0.018 | $0.0179 | $0.018 | $0.0179 | 555 | 06-24-2024 |
$0.0161 | $0.0173 | $0.0161 | $0.0188 | $0.0161 | 11,045 | 06-21-2024 |
$0.017 | $0.0171 | $0.017 | $0.0171 | $0.017 | 3,700 | 06-20-2024 |
$0.019 | $0.019 | $0.019 | $0.021 | $0.019 | 11,142 | 06-17-2024 |
$0.0209 | $0.0228 | $0.0209 | $0.023 | $0.01995 | 31,780 | 06-14-2024 |
$0.023 | $0.02 | $0.023 | $0.023 | $0.019 | 2,149 | 06-13-2024 |
$0.0248 | $0.0246 | $0.0248 | $0.0249 | $0.0224 | 926 | 06-12-2024 |
$0.0225 | $0.0248 | $0.0225 | $0.025 | $0.0225 | 401 | 06-11-2024 |
$0.025 | $0.03 | $0.025 | $0.03 | $0.025 | 3,902 | 06-10-2024 |
$0.027 | $0.027 | $0.027 | $0.027 | $0.027 | 909 | 06-07-2024 |
$0.025 | $0.026956 | $0.025 | $0.026956 | $0.025 | 5,214 | 06-06-2024 |
$0.0222 | $0.0187 | $0.0222 | $0.027 | $0.0171 | 82,801 | 06-05-2024 |
$0.0183 | $0.018 | $0.0183 | $0.0186 | $0.0174 | 8,700 | 06-04-2024 |
News, Short Squeeze, Breakout and More Instantly...
Celularity Inc. Warrant Company Name:
CELUW Stock Symbol:
NASDAQ Market:
Celularity Inc. Warrant Website:
FLORHAM PARK, N.J., June 03, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ: CELU) (“Celularity”), a regenerative and cellular medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products, announced today that it presented in vivo ...
FLORHAM PARK, N.J., May 24, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”), a regenerative medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products, announced today that on May 21, 2024, the Compa...
FLORHAM PARK, N.J., May 14, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ: CELU) (“Celularity”), a regenerative and cellular medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products, announced today that the Journa...